Chen Bihua 13D and 13G filings for MoonLake Immunotherapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:05 pm Purchase | 2023-12-31 | 13G | MoonLake Immunotherapeutics MLTX | Chen Bihua | 8,494,151 14.170% | 1,602,051 (+23.24%) | Filing |
| 2023-03-31 4:23 pm Purchase | 2022-12-31 | 13G | MoonLake Immunotherapeutics MLTX | Chen Bihua | 6,892,100 17.600% | 6,892,100 (New Position) | Filing |